Vaughan Nelson Investment Management L.P. Acquires 28,355 Shares of Allegion PLC $ALLE - MarketBeat
π Vaughan Nelson Investment Management raised its Allegion stake by 22.7% in Q1, adding 28,355 shares for a total holding of 153,511 shares worth $22.3 million.
π° Allegion authorized a new $500 million share repurchase program and declared a quarterly dividend of $0.55 per share payable on June 30th.
π Q1 EPS of $1.80 missed the consensus estimate of $1.88, though revenue of $1.03 billion matched analyst expectations exactly.
π Revenue grew 9.7% year-over-year to $1.03 billion with a net margin of 15.24% and return on equity of 35.41%.
π Analyst sentiment remains mixed with a consensus 'Hold' rating and an average price target of $160.89.
π Longbow Research upgraded Allegion to 'Buy' with a $165 target price following the earnings report.
π Morgan Stanley lowered its price objective from $165 to $142 and maintained an 'Equal Weight' rating.
π¦ Institutional ownership stands at 92.21%, with major holders including Boston Partners, State Street, and Geode Capital increasing or maintaining positions.
π SVP Robert C. Martens sold 3,993 shares in a transaction worth $547,640, reducing his personal stake by 31.78%.
π― The company set FY 2026 EPS guidance between $8.70 and $8.90, slightly below the average analyst expectation of $8.73.
- Vaughan Nelson Investment Management increased its stake by 22.7% in Q1, adding 28,355 shares to a total holding of 153,511 shares valued at $22.3 million.
- The company authorized a $500 million share repurchase program, allowing the purchase of up to 3.9% of outstanding shares.
- Allegion declared a quarterly dividend of $0.55 per share, representing an annualized yield of 1.7% and a payout ratio of 30.05%.
- Longbow Research upgraded Allegion from 'Neutral' to 'Buy' with a price target of $165.00.
- Revenue grew 9.7% year-over-year to $1.03 billion, demonstrating solid top-line growth despite the EPS miss.
- The company maintains a strong balance sheet with a current ratio of 1.91 and a debt-to-equity ratio of 0.97.
- Q1 EPS of $1.80 missed the analyst consensus estimate of $1.88 by $0.08.
- Morgan Stanley lowered its price objective from $165.00 to $142.00 and downgraded the rating to 'Equal Weight'.
- JPMorgan Chase reduced its price target from $170.00 to $150.00 while maintaining a 'Neutral' rating.
- Barclays lowered its price target from $165.00 to $161.00 and set an 'Equal Weight' rating.
- SVP Robert C. Martens sold 3,993 shares in a transaction worth $547,640, reducing his personal stake by 31.78%.